EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanoplatforms as Solutions to Overcome Chemoresistance in Cancer Therapy

Wanyu Wang, Fuming Liang iD, Lingli Zhang, Xiang Gao iD

ACS Nano · 2026

DOI: 10.1021/acsnano.6c11091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Nano, 2026. Verfasst von Wanyu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medic…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit nennt 465 Literaturangaben. Gefördert von: National Key Research and Development Program of China, 1?3?5 Project for Disciplines of Excellent, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor chemoresistance, driven by mechanisms such as drug efflux, DNA repair, apoptosis inactivation, immunosuppressive microenvironments, and the maintenance of cancer stem cell (CSC) stemness, remains a major obstacle to effective chemotherapy and patient prognosis. Engineered nanoplatforms offer multifaceted strategies to overcome these barriers, including passive targeting, ligand-mediated active targeting, and membrane-mimetic camouflage for enhanced tumor accumulation. Stimuli-responsive and prodrug-based systems exploit tumor microenvironmental features, such as low pH, high glutathione, enzyme overexpression, and redox gradients, to achieve precise spatiotemporal drug release while avoiding efflux and inactivation. Codelivery of chemotherapeutics with sensitizers, immunotherapeutic agents, gene therapeutics, or physical stimuli enables synergistic intervention across multiple resistance pathways. Critically, CSC-targeted nanoplatforms selectively eliminate the root causes of tumor relapse and metastasis. By integrating targeted delivery, controlled release, multidrug synergy, and CSC elimination, nanotechnology platforms transform the management of chemoresistance from passive mitigation toward proactive prevention, offering a promising foundation for clinical translation and personalized cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmNeoplasmsAntineoplastic AgentsNanoparticlesHumansNeoplastic Stem CellsAnimalsTumor MicroenvironmentNanomedicine

Stichwörter der Autor:innen

cancer stem cellschemoresistancecombination therapynanomedicinenanoplatformspersonalized cancer therapystimuli-responsive systemstargeted drug deliverytumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University and Collaborative Innovation Center for…
  • Department of Pharmacy, West China Second University Hospital of Sichuan University, Chengdu610041, P. R. China.
  • Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu610041, P. R. China.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu610041, P. R. China.
  • Children's Medicine Key Laboratory of Sichuan Province, West China Second University Hospital, Sichuan University, Chengdu, Sichuan610041, P. R. China.

ORCID-Profile: Fuming Liang, Xiang Gao

Förderung

  • National Key Research and Development Program of China
  • 1?3?5 Project for Disciplines of Excellent, West China Hospital, Sichuan University

Zitieren

APA

Wang, W., Liang, F., Zhang, L., & Gao, X. (2026). Nanoplatforms as Solutions to Overcome Chemoresistance in Cancer Therapy. ACS Nano. https://doi.org/10.1021/acsnano.6c11091

Vancouver

Wang W, Liang F, Zhang L, Gao X. Nanoplatforms as Solutions to Overcome Chemoresistance in Cancer Therapy. ACS Nano. 2026. doi:10.1021/acsnano.6c11091

BibTeX
@article{Wang2026,
  author = {Wang, Wanyu and Liang, Fuming and Zhang, Lingli and Gao, Xiang},
  title = {Nanoplatforms as Solutions to Overcome Chemoresistance in Cancer Therapy},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c11091}
}
Kostenlos starten →